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The physiological functions of SAA have yet to be firmly established. SAA reportedly promotes several potentially atherosclerotic effects, including monocyte chemotaxis, 11 subendothelial lipoprotein retention, 8, 12 endothelial dysfunction, 13, 14 and proinflammatory cytokine 15, 16 and matrix metalloproteinase 17 induction. However, many of these effects were defined using commercially available SAA, which is a hybrid molecule containing sequences corresponding to both human acute phase SAA isoforms. Recent evidence suggests that this recombinant SAA may exert proinflammatory activities not shared by native SAA. 18 Simons et al 19 recently described a transgenic mouse with inducible, liver-specific expression of SAA1.1. Notably, induction of SAA to levels corresponding to severe inflammation (>1000 mg/L) had no effect on plasma levels of murine serum amyloid P component, an acute phase reactant that is typically induced in response to inflammatory stimuli. Thus, evidence that SAA is intrinsically proinflammatory has come under question.
Many published in vitro studies have investigated lipidfree/lipid-poor SAA, and not HDL-associated SAA, which may be the more physiologically relevant form of SAA because SAA in plasma is predominantly associated with HDL. In studies that investigated SAA complexed to HDL, the adverse effects observed for lipid-free/lipid-poor SAA seemed to be abrogated. 20, 21 Conversely, by associating with HDL, SAA may contribute to atherosclerotic processes by interfering with protective functions of HDL. For example, SAA has been suggested to modulate the ability of HDL to facilitate reverse cholesterol transport to remove excess cholesterol from the periphery (including cholesterol-laden macrophages in an atherosclerotic plaque) to the liver for excretion from the body. Several groups have reported that macrophage to feces reverse cholesterol transport is impeded in mice during inflammation. [22] [23] [24] [25] However, although SAA, in the absence of an acute phase response, modestly reduces reverse cholesterol transport in mice, 23 impairment of reverse cholesterol transport during an acute phase response does not require SAA. 25 Direct evidence that SAA promotes atherogenic processes is supported by a recent study in which administration of a lentiviral vector expressing mouse SAA produced a modest, but significant increase in atherosclerotic lesion areas of apolipoprotein E-deficient (apoE −/− ) mice. 26 However, because of lack of suitable animal models, there has been no direct evidence to date that endogenous SAA is required for atherosclerotic lesion formation. We recently reported the development of mice deficient in both acute phase SAA isoforms. 27 Generation of these mice was complicated by the fact that SAA1.1 and SAA2.1 are located ≈9 kb apart in opposite orientation on mouse chromosome 7, which hindered multiple attempts to target both genes simultaneously. For the current study, SAA-deficient mice were crossed with apoE −/− mice to determine whether lack of SAA alters the extent of either spontaneous or diet-induced atherosclerotic lesions.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

SAA Deficiency Does Not Affect Atherosclerotic Lipid Deposition in ApoE −/− Mice Fed a Normal Rodent Diet
In a previous study, overexpression of SAA using a lentiviral vector enhanced atherosclerosis development in apoE −/− mice fed a normal rodent diet. 26 We detected SAA by immunohistochemical staining in aortic root lesions of 50-week-old apoE −/− mice fed a normal diet, confirming an earlier report 8 ( Figure I in the online-only Data Supplement). To investigate whether endogenous SAA contributes to atherosclerotic lipid deposition in apoE −/− mice, we fed apoE −/− mice (SAAWT) and apoE −/− mice lacking both acute phase SAA isoforms (SAAKO mice) a normal rodent diet for 50 weeks. Neither strain exhibited any overt signs of adverse health during the course of the study. Body weights were determined at the onset of the experiment and monitored up to study termination at 50 weeks. As expected, male mice weighed more than female mice throughout the study (Table 1) . Unexpectedly, female SAAKO mice gained more weight than SAAWT mice during the course of the experiment. At study termination, female SAAKO mice exhibited a modest but significant 10.3% increase in weight compared with female SAAWT mice ( Table 1 ; P<0.05). The difference in body weight was largely attributed to an increase in fat mass in female SAAKO mice ( Figure II in the online-only Data Supplement), which was not accounted for by significant differences in fatty acid synthase expression in adipose tissue ( Figure IIIA in the online-only Data Supplement). The increased adiposity in female SAAKO mice was not associated with markedly increased markers of inflammation. Although plasma levels of interleukin (IL)-1β were higher in male SAAKO mice when compared with those in SAAWT mice (P<0.05), the levels of both IL-1β and IL-6 in all groups of mice were barely above the level of detection (Table 1 ). Thus, the physiological relevance of differences in IL-1β levels in male mice is uncertain. There was a trend for decreased abundance of F4/80 mRNA, a macrophage marker, in gonadal fat from female SAAKO mice compared with that from SAAWT mice; however, the difference did not reach statistical significance (P=0.06; Figure IIIB in the online-only Data Supplement). The abundance of arginase, IL-10, tumor necrosis factor-α, and IL-6 mRNAs in adipose tissue of female SAAWT and SAAKO mice was also similar, suggesting that increased adiposity in SAAKO mice did not lead to changes in macrophage polarity ( Figure IIIC -IIIF in the online-only Data Supplement). Plasma total cholesterol concentrations were similar in male SAAKO and SAAWT mice and modestly but significantly higher in 50-week-old female SAAKO mice when compared with those in SAAWT mice (22% increase; P<0.05; Table 1 ). Differences in plasma cholesterol concentrations were not reflected in altered lipoprotein cholesterol distributions of either male or female SAAWT and SAAKO mice ( Figure IV in the online-only Data Supplement). Although plasma triglyceride concentrations were higher in male mice when compared with those in female mice, SAA deficiency had no effect on triglyceride concentrations in either sex (Table 1) . Plasma SAA concentrations were detectable but low in 50-week-old apoE −/− mice (SAAWT) fed a normal laboratory diet and did not differ between males and females ( Table 1) . Atherosclerotic lesion areas were measured on the intimal surfaces of the total aorta including the ascending aorta to bifurcation in all groups of mice by en face analyses ( Figure 1 ). Lesion area as a percentage of the total aorta in male SAAWT (10.3±1.7), male SAAKO (11.7±1.1), female SAAWT (11.1±1.2), and female SAAKO (11.5±0.6) mice were not significantly different. Thus, endogenously expressed SAA in either male or female SAAWT mice fed a normal rodent diet does not affect the extent of aortic atherosclerotic lesions, despite modest increases in plasma cholesterol and body weight, at least in female mice.
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SAA Deficiency Does Not Affect Atherosclerotic Lesion Development in ApoE −/− Mice Fed a Western Diet
The lack of an effect of SAA deficiency on atherosclerosis development in mice fed a normal rodent diet could be because of the relatively low concentrations of plasma SAA in this setting (≈17 μg/mL). Therefore, male and female SAAWT and SAAKO mice were challenged with a diet enriched in saturated fat for 12 weeks, which is known to increase plasma SAA concentrations. 28 Although there were sex differences in body weight, plasma lipid concentrations, and lean and fat mass in both strains after high-fat feeding, SAA deficiency had no effect on any of these parameters in either male or female mice ( Table 2 ; Figure V in the onlineonly Data Supplement). Lipoprotein cholesterol distributions, as determined by size-exclusion chromatography, were similar in SAAWT and SAAKO mice ( Figure VI in the online-only Data Supplement). Plasma cytokine concentrations (IL-6 and IL-1β) were determined as an index of systemic inflammation evoked by feeding a Western diet for 12 weeks (Table 2) . Although somewhat elevated compared with mice fed a normal rodent diet for 50 weeks, plasma cytokine concentrations were low and not significantly different between the 2 strains. Based on quantitative immunoblotting, the Western diet increased plasma SAA concentrations ≈5.0-fold in male apoE −/− (SAAWT) mice and ≈10.6-fold in female SAAWT mice ( Figure 2 ). As determined by ELISA, plasma SAA concentrations were highly variable in individual male and female SAAWT mice after high-fat feeding, ranging from virtually undetectable values to >1 mg/mL for both sexes ( Table 2) . Plasma SAA concentrations in age-matched control male SAAWT mice were 18.8±7.3 μg/mL. Mice with the largest induction of plasma SAA also exhibited the highest levels of IL-6 and IL-1β (data not shown).
Atherosclerotic lesion area, expressed as the percentage of total aortic surface of male SAAWT (14.1±1.3), male SAAKO (14.5±1.1), female SAAWT (13.3±0.8), and female SAAKO (14.7±1.0) mice (Figure 3 ), was not significantly influenced by sex or genotype. Atherosclerotic lesion areas within the arch region, where lesions were relatively more abundant, were also similar for the 4 groups (not shown). Additional analyses of male mice indicated that lesion areas in the aortic root, quantified after oil red O staining of neutral lipids, as well as the macrophage content of the aortic root lesions, quantified by CD68 immunostaining, were also not significantly different in SAAWT when compared with those in SAAKO mice (Figure 4 ; Figure VII in the online-only Data Supplement). In SAAWT mice, plasma SAA concentrations did not correlate with atherosclerotic lesion area measured en face ( Figure 5 ) or within aortic roots (not shown). Taken together, these data indicate that endogenous SAA does not significantly affect body weights, plasma lipid concentrations and lipoprotein profiles, or atherosclerotic lesion development in either male or female apoE −/− (SAAWT) mice fed an atherosclerotic diet for 12 weeks.
Discussion
It is widely recognized that inflammation contributes significantly to the initiation, progression, and rupture of 
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SAAWT February 2014 atherosclerotic plaques. SAA is an inflammatory marker that has been associated strongly with increased risk for clinical cardiovascular events. However, whether SAA is actively involved in atherogenesis or merely serves as a marker of atherogenic processes has not been established clearly. In this study, we determined whether apoE −/− mice lacking SAA are protected from atherosclerosis. Our data clearly show that deficiency of both acute phase forms of SAA does not affect the extent of atherosclerotic lipid deposition that spontaneously occurs in apoE −/− mice fed a normal rodent diet or that is induced by a Western diet. Our results also indicate that plasma SAA levels do not correlate with atherosclerotic lesion area in aortas of apoE −/− mice, in contrast to what was reported for low-density lipoprotein receptor deficient mice fed a highfat diet with or without addition of cholesterol. 28 Despite the observation by Dong et al 26 that increased plasma SAA concentration contributes to accelerated atherosclerosis, we conclude that endogenous SAA is not required for atherosclerotic lipid deposition in this murine model. The lack of reduction of atherosclerosis in SAAKO mice does not negate a role for SAA in atherogenesis, but demonstrates that it is not required. We noted that female SAAKO mice had a modest but significant increase in weight gain and percentage body fat during the 50-week study compared with female SAAWT mice. In contrast, 50-week-old male SAAKO mice did not show a significant difference in weight when compared with SAAWT mice. It should be noted, however, that the modest increase in adiposity in 50-week-old female SAAKO mice was not associated with increased plasma levels or adipose tissue expression of inflammatory cytokines. Thus, the extent of atherosclerosis in female SAAWT and SAAKO mice fed the normal rodent diet was not influenced in the 2 strains by major differences in systemic inflammation. In the course of studying the impact of SAA deficiency in normolipidemic (C57BL/6) mice, we have observed that both male and female SAAKO mice gained less weight compared with their wild-type counterparts. The difference in weight gain can be attributed to differences in fat mass (FC de Beer, MC de Beer, unpublished data, 2011). Thus, SAA may regulate adiposity through mechanisms that are modulated by hyperlipidemia and sex. Abundant data from both human and mouse studies establish that increased adiposity is associated with increased SAA concentrations. Inflammatory cytokines produced by adipose tissue can act locally to induce SAA expression or enter the circulation and stimulate hepatic secretion of SAA. A strong correlation between body mass index and plasma SAA concentrations is seen in children and adults, 29, 30 and weight loss is accompanied by a reduction in plasma SAA. 4, 31 Obese mice also have elevated circulating SAA concentrations, 32 and we previously reported an association between elevated SAA in obesity and increased atherosclerosis in apoE −/− mice. 9 Our data in SAAKO mice highlight the need for further studies addressing the complex relationship between SAA and adiposity.
The wide variations in plasma SAA concentrations in apoE −/− mice after 12 weeks on the Western diet provided the opportunity to determine whether circulating SAA concentrations predicted the extent of atherosclerotic lesion area in our study. The finding that plasma SAA concentrations did not correlate with atherosclerotic lesion area in apoE −/− mice fed a high-fat diet supports our conclusion that SAA does not play a major role in atherosclerotic lipid deposition in this mouse strain. However, in an earlier study, Lewis et al 28 determined that plasma concentrations of SAA, but not cholesterol, correlated with the extent of atherosclerosis in low-density lipoprotein receptor deficient mice fed a normal, high-fat, or high-fat and high-cholesterol diet for 10 weeks. This finding led the authors to conclude that SAA may have a causal role in atherosclerosis. In that study, atherosclerotic lipid deposition was expressed as total lesion area in the aortic arch region, which complicates our ability to make direct comparisons with our data. The possibility that SAA may contribute to atherosclerotic mechanisms in low-density lipoprotein receptor deficient mice, but not apoE −/− mice, merits further investigation.
In a recently published study, Dong et al 26 Table 2 ), individual plasmas were pooled for each group, and triplicate aliquots (1.5 μL) from each pool were subjected to SDS-PAGE and immunoblotted for SAA using rabbit antimouse antisera (De Beer laboratory). compared with those in control mice (35.5±9.6 and 8.5±2.8 μg/mL, respectively). Increased SAA was associated with significantly increased lesion areas on both the luminal surface of the aorta and in the aortic root. These findings are in contrast to our results, which show no effect of SAA deficiency on atherosclerotic lesion area in apoE −/− mice fed a normal rodent diet for 50 weeks or in mice fed a Western diet for 12 weeks. The reason for the discrepant results from the 2 studies is unclear. Although no data support this suggestion, we cannot rule out the possibility that SAA1.1 and SAA2.1 have opposing effects on atherosclerosis in vivo such that overexpression of SAA1.1 increases atherosclerosis, whereas deficiency of both SAA isoforms has no effect. More likely, however, is the possibility that plasma levels of SAA in 50-week-old SAAWT mice (≈17 μg/mL) were too low to have a major effect on atherosclerosis in our study. However, the extreme hypercholesterolemia evoked by high-fat diet feeding may have overwhelmed any modest atherogenic effects exerted by endogenous SAA. Notably, Dong et al reported no effect of exogenous SAA expression on accelerated atherosclerosis produced by high-fat diet feeding, supporting the conclusion that SAA plays a minor role in this setting. As another approach to investigate the role of endogenous SAA in atherogenesis, we recently performed studies to determine whether SAAKO mice are protected from angiotensin II-induced atherosclerosis (manuscript in preparation). Angiotensin II infusion resulted in plasma SAA levels (192.1±126.9 μg/mL) in male SAAWT mice that were in the range of values induced by 12-week Western diet feeding ( Table 2 ) without altering plasma cholesterol levels. However, despite the increase in circulating SAA, atherosclerotic lesion areas were similar in SAAWT and SAAKO mice after angiotensin II infusion, indicating that endogenous SAA does not play a role in accelerated atherosclerosis induced by angiotensin II. Taken together, comprehensive studies under 3 experimental conditions strongly support the conclusion that endogenous SAA, expressed at levels achieved in our studies, does not affect atherosclerotic lipid deposition in apoE-deficient mice.
Although our data clearly establish that SAA is not essential for atherosclerotic lipid deposition in a widely used mouse model, we cannot ignore abundant evidence that this acute phase reactant is strongly linked to human cardiovascular disease. Patients with elevated plasma SAA concentrations have higher rates of adverse events (death, myocardial infarction, or urgent target-vessel revascularization) at 30 days irrespective of whether another acute phase reactant, C-reactive protein, is elevated. 7 In patients with acute myocardial infarction, concentrations of SAA, but not C-reactive protein, are increased at the site of plaque rupture. 33 Acute phase SAA has been conserved through ≈500 million years of evolution, and during severe inflammation it can account for as much as 2.5% of hepatic protein production. 34 Thus, from an evolutionary perspective, acute phase SAA should perform an important survival role in the systemic response to acute injury and infection, with HDL likely serving as the vehicle for transporting SAA from the liver to sites of tissue injury. Consistent with this concept, SAA has been implicated in several processes important for tissue remodeling and repair, including leukocyte chemotaxis, 35, 36 inflammatory cytokine induction, 15, 16, 26 and upregulation of genes involved in extracellular matrix remodeling, including transforming growth factor-β 12 and matrix metalloproteinases. 17 However, many of these potentially atherogenic effects were based on studies using a commercially available hybrid SAA that is not identical to any known SAA isoform. A recent study suggests that this recombinant molecule may exert some effects not elicited by human or mouse SAAs. 18 In our studies, the absence of endogenous acute phase SAA did not affect the macrophage content of atherosclerotic lesions in the aortic root of male mice fed a Western diet for 12 weeks nor the expression of macrophage and inflammatory markers in the adipose tissue of female mice fed a normal rodent diet for 50 weeks. In a recent study, high-level expression of SAA1.1 in a transgenic mouse did not evoke an inflammatory response, providing additional evidence that SAA may not be intrinsically proinflammatory. 19 Nevertheless, in the setting of chronic inflammation, such as rheumatoid arthritis, 1 obesity, 3, 4 and diabetes mellitus and insulin resistance, 2,3 modest and sustained increases in SAA may contribute to maladaptive remodeling of atherosclerotic lesions, leading to plaque instability and rupture. Thus, further studies are needed to determine whether SAA promotes cardiovascular disease events through pathological actions that occur during later stages of atherosclerosis. 
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